Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 181 entries
View as:

Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01765478 Org: User:
Start: 01/31/13 End: 11/30/14 Due: 11/30/15

Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT01505777 Org: User:
Start: 05/31/11 End: 06/30/12 Due: 06/30/13

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT03353350 Org: User:
Start: 12/05/17 End: 09/07/20 Due: 09/07/21

Efficacy and Safety of HIP1601 Capsule

Phase: N/A Priority: Normal
NCT ID: NCT04080726 Org: User:
Start: 10/25/18 End: 12/03/19 Due: 12/03/20

Molar Potency Study of HM12460A in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03330314 Org: User:
Start: 10/24/17 End: 02/08/18 Due: 02/08/19

Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(Sonefpeglutide) in Healthy Korean Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04076293 Org: User:
Start: 10/08/19 End: 05/03/21 Due: 05/03/22

Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01463982 Org: User:
Start: 12/31/10 End: 12/31/13 Due: 12/31/14

Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)

Phase: N/A Priority: Normal
NCT ID: NCT04252963 Org: User:
Start: 11/02/18 End: 05/31/21 Due: 05/31/22

An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT05487560 Org: User:
Start: 04/18/19 End: 06/22/22 Due: 06/22/23

Trial to Evaluate the Efficacy and Safety of HCP1302

Phase: N/A Priority: Normal
NCT ID: NCT02587988 Org: User:
Start: 09/30/14 End: 08/31/15 Due: 08/31/16

Effect of LAPS-Exendin on Body Weight in Obese Population

Phase: N/A Priority: Normal
NCT ID: NCT02075281 Org: User:
Start: 02/28/14 End: 02/28/15 Due: 02/28/16

Evaluating the Bioequivalence of HIP1302, HGP1406

Phase: N/A Priority: Normal
NCT ID: NCT02545829 Org: User:
Start: 08/31/15 End: 10/31/15 Due: 10/31/16

A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04081857 Org: User:
Start: 06/03/19 End: 08/05/19 Due: 08/05/20

Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

Phase: N/A Priority: Normal
NCT ID: NCT02127320 Org: User:
Start: 06/30/14 End: 11/30/14 Due: 11/30/15

An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol

Phase: N/A Priority: Normal
NCT ID: NCT04788290 Org: User:
Start: 11/06/17 End: 07/13/20 Due: 07/13/21

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06234397 Org: User:
Start: 12/28/23 End: 01/31/28 Due: 01/31/29

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT05407220 Org: User:
Start: 06/29/22 End: 07/25/22 Due: 07/25/23

Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01037543 Org: User:
Start: 11/30/09 End: 04/30/11 Due: 04/30/12

A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT04074551 Org: User:
Start: 07/16/19 End: 03/17/20 Due: 03/17/21

A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

Phase: N/A Priority: Normal
NCT ID: NCT01447797 Org: User:
Start: 09/30/11 End: 12/31/11 Due: 12/31/12

FLX475 Combined with Pembrolizumab in Patients with Advanced or Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04768686 Org: User:
Start: 05/18/21 End: 08/12/24 Due: 08/12/25

Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04044170 Org: User:
Start: 07/30/19 End: 04/13/20 Due: 04/13/21

Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT01564875 Org: User:
Start: 12/31/10 End: 05/31/12 Due: 05/31/13

Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01514903 Org: User:
Start: 12/31/11 End: 12/31/11 Due: 12/31/12

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02712411 Org: User:
Start: 07/31/15 End: 09/30/15 Due: 09/30/16